GCM
EOLS icon

Glenview Capital Management’s Evolus EOLS Stock Holding History

Glenview Capital Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-394,810
Closed -$4.43M – 60
2022
Q1 		$4.43M Buy
394,810
+983
+0.2% +$8.38K 0.09% 55
2021
Q4 		$2.56M Buy
+393,827
New +$2.7M 0.05% 57

Other funds holding EOLS

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
AC
AWH Capital Dallas, Texas $110M AUM 44.24% 1-Year Est. Return

Glenview Capital Management's EOLS Position: Q2 2022 in Review

Glenview Capital Management sold out of Evolus (EOLS) in Q2 2022, closing a stake of 394,810 shares — an estimated $4.43M sold.

Glenview Capital Management first reported a position in EOLS in Q4 2021 and held it in 2 quarters. The position peaked at $4.43M in Q1 2022. 123 funds tracked by Wall St. Rank hold EOLS as of Q2 2022.

  • Glenview Capital Management reported no remaining Evolus position as of Q2 2022 after selling out during the quarter.
  • Glenview Capital Management sold 394,810 Evolus shares in Q2 2022, an estimated $4.43M.
  • Glenview Capital Management first reported a position in Evolus in Q4 2021 and held it in 2 quarters.
  • Glenview Capital Management's Evolus position peaked at $4.43M in Q1 2022.
  • 123 funds tracked by Wall St. Rank held Evolus as of Q2 2022.

Based on Glenview Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.